Trials / Completed
CompletedNCT01283958
The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
Study of the Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the evaluation of targeted therapies. Iloprost, a prostacyclin analogue, is one such targeted therapy used in patients with Eisenmenger's syndrome. The purpose of our study is to assess the effects of inhaled iloprost on patients with Eisenmenger's syndrome.
Conditions
Timeline
- Start date
- 2007-09-01
- Completion
- 2010-05-01
- First posted
- 2011-01-26
- Last updated
- 2011-01-26
Source: ClinicalTrials.gov record NCT01283958. Inclusion in this directory is not an endorsement.